{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T00:11:05Z","timestamp":1719619865865},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina de Familia. SEMERGEN"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.semerg.2023.102176","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T01:06:45Z","timestamp":1706749605000},"page":"102176","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["La gota, m\u00e1s all\u00e1 de la articulaci\u00f3n: \u00bfc\u00f3mo debemos tratarla?"],"prefix":"10.1016","volume":"50","author":[{"given":"M.A.","family":"Pou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Martinez-Laguna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Diaz-Torne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semerg.2023.102176_bib0250","doi-asserted-by":"crossref","first-page":"105257","DOI":"10.1016\/j.jbspin.2021.105257","article-title":"Prevalence of gout in the adult general population in Spain: Estimating the proportion of undiagnosed cases","volume":"89","author":"Quilis","year":"2022","journal-title":"Joint Bone Spine."},{"key":"10.1016\/j.semerg.2023.102176_bib0255","doi-asserted-by":"crossref","first-page":"e13937","DOI":"10.1111\/eci.13937","article-title":"Global burden of gout in 1990-2019: A systematic analysis of the Global Burden of Disease study 2019","volume":"53","author":"Jeong","year":"2023","journal-title":"Eur J Clin Invest."},{"key":"10.1016\/j.semerg.2023.102176_bib0260","doi-asserted-by":"crossref","first-page":"e001015","DOI":"10.1136\/rmdopen-2019-001015","article-title":"Failure to reach uric acid target of <0.36 mmol\/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality","volume":"5","author":"P\u00e9rez Ruiz","year":"2019","journal-title":"RMD Open."},{"key":"10.1016\/j.semerg.2023.102176_bib0265","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S2665-9913(20)30221-6","article-title":"Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout","volume":"3","author":"Hansildaar","year":"2021","journal-title":"Lancet Rheumatol."},{"key":"10.1016\/j.semerg.2023.102176_bib0270","first-page":"1","article-title":"Sex and country differences in gout: cross-country comparison between Sweden and the UK","volume":"23","author":"Dehlin","year":"2023","journal-title":"Scand J Rheumatol."},{"key":"10.1016\/j.semerg.2023.102176_bib0275","doi-asserted-by":"crossref","first-page":"105628","DOI":"10.1016\/j.jbspin.2023.105628","article-title":"Validation of gout diagnosis in electronic primary care medical records: A population-based study","volume":"90","author":"Pou","year":"2023","journal-title":"Joint Bone Spine."},{"key":"10.1016\/j.semerg.2023.102176_bib0280","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40744-017-0091-1","article-title":"Improvement in Diagnosis and Treat-to-Target Management of Hyperuricemia in Gout: Results from the GEMA-2 Transversal Study on Practice","volume":"5","author":"Perez Ruiz","year":"2018","journal-title":"Rheumatol Ther."},{"key":"10.1016\/j.semerg.2023.102176_bib0285","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1080\/03007995.2020.1799774","article-title":"Gout in primary healthcare: still a long way to go","volume":"36","author":"Pou","year":"2020","journal-title":"Curr Med Res Opin."},{"key":"10.1016\/j.semerg.2023.102176_bib0290","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/rheumatology\/kex530","article-title":"Key barriers to gout care: a systematic review and thematic synthesis of qualitative studies","volume":"57","author":"Rai","year":"2018","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.semerg.2023.102176_bib0295","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1001\/jama.2016.3517","article-title":"Trends in Gout and Rheumatoid Arthritis Hospitalizations in the United States, 1993-2011","volume":"315","author":"Lim","year":"2016","journal-title":"JAMA."},{"key":"10.1016\/j.semerg.2023.102176_bib0300","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1136\/annrheumdis-2016-210588","article-title":"The unclosing premature mortality gap in gout: a general population-based study","volume":"76","author":"Fisher","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.semerg.2023.102176_bib0305","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.2174\/138161205774913255","article-title":"Uric acid and oxidative stress","volume":"11","author":"Glantzounis","year":"2005","journal-title":"Curr Pharm Des."},{"key":"10.1016\/j.semerg.2023.102176_bib0310","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nrrheum.2015.125","article-title":"Mechanisms of crystal formation in gout-a structural approach","volume":"11","author":"Pascual","year":"2015","journal-title":"Nat Rev Rheumatol."},{"key":"10.1016\/j.semerg.2023.102176_bib0315","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/art.1780150209","article-title":"The influence of temperature on the solubility of monosodium urate","volume":"15","author":"Loeb","year":"1972","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semerg.2023.102176_bib0320","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13075-021-02444-8","article-title":"The comparative effect of exposure to various risk factors on the risk of hyperuricaemia: diet has a weak causal effect","volume":"23","author":"Topless","year":"2021","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.semerg.2023.102176_bib0325","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/ard.2011.154997","article-title":"Diagnosis of gout in patients with asymptomatic hyperuricaemia: a pilot ultrasound study","volume":"71","author":"De Miguel","year":"2012","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.semerg.2023.102176_bib0330","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","article-title":"Gout","volume":"397","author":"Dalbeth","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.semerg.2023.102176_bib0335","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1093\/rheumatology\/keab335","article-title":"The inflammatory role of silent urate crystal deposition in intercritical gout","volume":"60","author":"Diaz-Torne","year":"2021","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.semerg.2023.102176_bib0340","doi-asserted-by":"crossref","first-page":"o1754","DOI":"10.1136\/bmj.o1754","article-title":"Guideline Committee. Gout: diagnosis and management-summary of NICE guidance","volume":"378","author":"Neilson","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/j.semerg.2023.102176_bib0345","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/art.39581","article-title":"Silent Monosodium Urate Crystal Deposits Are Associated With Severe Coronary Calcification in Asymptomatic Hyperuricemia: An Exploratory Study","volume":"68","author":"Andr\u00e9s","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.semerg.2023.102176_bib0350","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1093\/rheumatology\/keaa920","article-title":"Crystal deposition measured with dual-energy computed tomography: association with mortality and cardiovascular risks in gout","volume":"60","author":"Marty-An\u00e9","year":"2021","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.semerg.2023.102176_bib0355","doi-asserted-by":"crossref","first-page":"152273","DOI":"10.1016\/j.semarthrit.2023.152273","article-title":"All-cause and specific mortality in patients with gout: A systematic review and meta-analysis","volume":"63","author":"Wang","year":"2023","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.semerg.2023.102176_bib0360","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1136\/ard.2008.094201","article-title":"Mechanisms of bone erosion in gout: a quantitative analysis using plain radiography and computed tomography","volume":"68","author":"Dalbeth","year":"2009","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.semerg.2023.102176_bib0365","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ekir.2022.11.016","article-title":"Uric Acid and Chronic Kidney Disease: Still More to Do","volume":"8","author":"Johnson","year":"2022","journal-title":"Kidney Int Rep."},{"key":"10.1016\/j.semerg.2023.102176_bib0370","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3899\/jrheum.200113","article-title":"Sex Differences in the Clinical Profile Among Patients With Gout: Cross-sectional Analyses of an Observational Study","volume":"48","author":"Te Kampe","year":"2021","journal-title":"J Rheumatol."},{"key":"10.1016\/j.semerg.2023.102176_bib0375","doi-asserted-by":"crossref","first-page":"7578","DOI":"10.1038\/s41598-020-64587-z","article-title":"Sex- and age-specific variations, temporal trends and metabolic determinants of serum uric acid concentrations in a large population-based Austrian cohort","volume":"10","author":"Zitt","year":"2020","journal-title":"Sci Rep."},{"key":"10.1016\/j.semerg.2023.102176_bib0380","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/rheumatology\/keaa366","article-title":"Ultrasound for the diagnosis of gout-the value of gout lesions as defined by the Outcome Measures in Rheumatology ultrasound group","volume":"60","author":"Christiansen","year":"2021","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.semerg.2023.102176_bib0385","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/archinternmed.2010.196","article-title":"A diagnostic rule for acute gouty arthritis in primary care without joint fluid analysis","volume":"170","author":"Janssens","year":"2010","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.semerg.2023.102176_bib0390","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","article-title":"2015 Gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"74","author":"Neogi","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.semerg.2023.102176_bib0395","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/annrheumdis-2012-202594","article-title":"Gout treatment: should we aim for rapid crystal dissolution?","volume":"72","author":"Pascual","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.semerg.2023.102176_bib0400","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout","volume":"76","author":"Richette","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.semerg.2023.102176_bib0405","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10067-021-05872-8","article-title":"Early versus Late Allopurinol Initiation in Acute Gout Flare (ELAG): a randomized controlled trial","volume":"41","author":"Satpanich","year":"2022","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.semerg.2023.102176_bib0410","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1002\/art.34488","article-title":"Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol","volume":"64","author":"Stamp","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semerg.2023.102176_bib0415","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/annrheumdis-2017-211574","article-title":"Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre randomised study","volume":"77","author":"Yamanaka","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.semerg.2023.102176_bib0420","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(18)32158-5","article-title":"Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial","volume":"392","author":"Doherty","year":"2018","journal-title":"Lancet."},{"key":"10.1016\/j.semerg.2023.102176_bib0425","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.clinthera.2012.12.011","article-title":"Efficacy and tolerability of febuxostat in hyperuricemic patients with or without gout: a systematic review and meta-analysis","volume":"35","author":"Ye","year":"2013","journal-title":"Clin Ther."},{"key":"10.1016\/j.semerg.2023.102176_bib0430","doi-asserted-by":"crossref","first-page":"152073","DOI":"10.1016\/j.semarthrit.2022.152073","article-title":"Urate-lowering efficacy and renal safety of febuxostat in patients with hyperuricemia and stage 4-5 chronic kidney disease not yet on dialysis: A meta-analysis of observational studies","volume":"56","author":"Jeong","year":"2022","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.semerg.2023.102176_bib0435","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1002\/art.30649","article-title":"A two-stage approach to the treatment of hyperuricemia in gout: the \u201cdirty dish\u201d hypothesis","volume":"63","author":"Perez-Ruiz","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semerg.2023.102176_bib0440","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa1710895","article-title":"Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout","volume":"378","author":"White","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1016\/j.semerg.2023.102176_bib0445","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/art.41638","article-title":"Reassessing the Cardiovascular Safety of Febuxostat: Implications of the Febuxostat versus Allopurinol Streamlined Trial","volume":"73","author":"Choi","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.semerg.2023.102176_bib0450","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0140-6736(20)32234-0","article-title":"Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial","volume":"396","author":"Mackenzie","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.semerg.2023.102176_bib0455","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3111\/13696998.2016.1149482","article-title":"Cost-effectiveness analysis of febuxostat in patients with gout in Spain","volume":"19","author":"Perez-Ruiz","year":"2016","journal-title":"J Med Econ."},{"key":"10.1016\/j.semerg.2023.102176_bib0460","doi-asserted-by":"crossref","first-page":"101723","DOI":"10.1016\/j.berh.2021.101723","article-title":"Role of diet in hyperuricemia and gout","volume":"35","author":"Danve","year":"2021","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"10.1016\/j.semerg.2023.102176_bib0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10408398.2018.1503155","article-title":"Consumption of sugar sweetened beverages and dietary fructose in relation to risk of gout and hyperuricemia: a systematic review and meta-analysis","volume":"60","author":"Ebrahimpour-Koujan","year":"2020","journal-title":"Crit Rev Food Sci Nutr."},{"key":"10.1016\/j.semerg.2023.102176_bib0470","doi-asserted-by":"crossref","first-page":"e000081","DOI":"10.1136\/bmjmed-2021-000081","article-title":"Association between gout and cardiovascular outcomes in adults with no history of cardiovascular disease: large data linkage study in New Zealand","volume":"1","author":"Cai","year":"2022","journal-title":"BMJ Med."},{"key":"10.1016\/j.semerg.2023.102176_bib0475","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.27327","article-title":"High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study","volume":"62","author":"Terkeltaub","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.semerg.2023.102176_bib0480","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10067-015-2991-1","article-title":"Efficacy and safety of etoricoxib compared with NSAIDs in acute gout: a systematic review and a meta-analysis","volume":"35","author":"Zhang","year":"2016","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.semerg.2023.102176_bib0485","doi-asserted-by":"crossref","first-page":"464","DOI":"10.7326\/M14-2070","article-title":"Oral Prednisolone in the Treatment of Acute Gout: A Pragmatic, Multicenter, Double-Blind, Randomized Trial","volume":"164","author":"Rainer","year":"2016","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.semerg.2023.102176_bib0490","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s40256-020-00459-1","article-title":"Gout Pharmacotherapy in Cardiovascular Diseases: A Review of Utility and Outcomes","volume":"21","author":"Kaul","year":"2021","journal-title":"Am J Cardiovasc Drugs."}],"container-title":["Medicina de Familia. SEMERGEN"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359323002563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359323002563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T20:12:24Z","timestamp":1719605544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1138359323002563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1138359323002563"],"URL":"https:\/\/doi.org\/10.1016\/j.semerg.2023.102176","relation":{},"ISSN":["1138-3593"],"issn-type":[{"value":"1138-3593","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La gota, m\u00e1s all\u00e1 de la articulaci\u00f3n: \u00bfc\u00f3mo debemos tratarla?","name":"articletitle","label":"Article Title"},{"value":"Medicina de Familia. SEMERGEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semerg.2023.102176","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Sociedad Espa\u00f1ola de M\u00e9dicos de Atenci\u00f3n Primaria (SEMERGEN). Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102176"}}